Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/10/22
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022GlobeNewsWire • 11/02/22
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral SolutionGlobeNewsWire • 09/13/22
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/11/22
Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 08/04/22
Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)GlobeNewsWire • 07/18/22
Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/12/22
Eton Pharmaceuticals, Inc.'s (ETON) CEO Sean Brynjelsen on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/12/22
Analysts Estimate Eton Pharmaceuticals, Inc. (ETON) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/05/22
Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022GlobeNewsWire • 05/03/22
Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride InjectionGlobeNewsWire • 04/11/22
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/17/22